Virological and Biochemical Relapse after Discontinuation of Lamivudine Monotherapy for Chronic Hepatitis B in Japan: Comparison with Breakthrough Hepatitis during Long-Term Treatment

Publisher： Karger

E-ISSN： 1423-0100|48|2-3|174-182

ISSN： 0300-5526

Source： Intervirology, Vol.48, Iss.2-3, 2005-03, pp. : 174-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 381-388

Karger

Access to resources Recommend Favorite

Long-Term Results of Lamivudine Monotherapy in Korean Patients with HBeAg-Positive Chronic Hepatitis B: Response and Relapse Rates, and Factors Related to Durability of HBeAg Seroconversion

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 341-349

Karger

Access to resources Recommend Favorite

Short-Term Lamivudine for the Treatment of Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 367-372

Karger

Access to resources Recommend Favorite

Viral Breakthrough during Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 344-349

Karger

Access to resources Recommend Favorite

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance

By  

Intervirology, Vol. 57, Iss. 1, 2013-08 ,pp. : 8-16

Karger

Access to resources Recommend Favorite